{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T17:15:50Z","timestamp":1697217350040},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,6,20]],"date-time":"2003-06-20T00:00:00Z","timestamp":1056067200000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:p> <jats:italic>The management of anemia in uremic patients undergoing hemodialysis requires the appropriate combination of erythropoietin treatment, iron supplementation, and on occasion androgen therapy.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>Identifying and correcting functional iron deficiency is crucial to optimizing erythropoietin efficiency. Recently, however, the trend to administer maintenance iron with resultant high serum ferritin and high transferrin saturation has led to an increase in reports of iron overload.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>Oral iron supplementation is inexpensive and safe, but poor patient compliance and reduced intestinal absorption may limit its efficacy. Intravenous iron, on the other hand, is effective, and its safety is related to the iron salt used. Currently available data suggest that iron saccharate may be the safest iron salt available for intravenous administration, although iron gluconate is safer than the dextran forms of intravenous iron. It should be kept in mind, however, that all forms of intravenous iron may have the potential of inducing iron overload.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>At this time, the levels of ferritin that define iron overload are not clearly established. The side effects of iron overload are well recognized (infections, malignancies, vascular diseases); however, no guidelines exist for safe practice. There are many markers of iron deficiency, with serum ferritin and hypochromic red cell percentage currently the best markers available in clinical practice.<\/jats:italic> <\/jats:p>","DOI":"10.1046\/j.1492-7535.2003.00040.x","type":"journal-article","created":{"date-parts":[[2003,6,20]],"date-time":"2003-06-20T10:36:31Z","timestamp":1056105391000},"page":"216-221","source":"Crossref","is-referenced-by-count":0,"title":["Iron Management in Hemodialysis Patients: Optimizing Outcomes in Vicenza, Italy"],"prefix":"10.1111","volume":"7","author":[{"given":"C.","family":"Crepaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brendolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Carta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"D'Intini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gastaldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Inguaggiato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,6,20]]},"reference":[{"issue":"1","key":"e_1_2_8_2_2","first-page":"5","article-title":"The use of iron in patients on chronic dialysis: mistakes and misconeptions","volume":"11","author":"Sakiewicz P","year":"1998","journal-title":"J Nephrol."},{"issue":"1","key":"e_1_2_8_3_2","first-page":"S194","article-title":"Guidelines for anemia of chronic kidney disease","volume":"37","year":"2001","journal-title":"Am J Kid Dis."},{"key":"e_1_2_8_4_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/039139889802101108","article-title":"Iron in treatment of anemia in dialysis patients: an important support to erythropoietin","volume":"21","author":"Gallieni M","year":"1998","journal-title":"Int J Artif Organs."},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.1.82"},{"key":"e_1_2_8_6_2","first-page":"221","article-title":"Characterisation of iron availability from three different IV iron preparations in dialysis patients","volume":"8","author":"MacDougall IC","year":"1997","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027405"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.5.1076-a"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00314.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00436.x"},{"issue":"4","key":"e_1_2_8_11_2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/clinchem\/40.4.546","article-title":"When is a serum iron really a serum iron? The status of serum iron measurements","volume":"40","author":"Tietz NW","year":"1994","journal-title":"Clin Chem."},{"issue":"1","key":"e_1_2_8_12_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ajcp\/67.1.84","article-title":"Relationship of day\u2010to\u2010day variation of serum iron concentrations to iron\u2010binding capacity in healthy young women","volume":"67","author":"Statland BE","year":"1977","journal-title":"Am J Clin Pathol."},{"issue":"1","key":"e_1_2_8_13_2","first-page":"19","article-title":"Efficacy of transferrin determination in human sera in the diagnosis of iron deficiency","volume":"32","author":"Withold W","year":"1994","journal-title":"Eur J Clin Chem Clin Biochem."},{"issue":"5","key":"e_1_2_8_14_2","first-page":"14","article-title":"European best practice guidelines for the management of anaemia in patients with chronic renal failure. Target Guideline 6: Assessing and optimizing iron stores","volume":"14","year":"1999","journal-title":"Nephrol Dial Transplant."},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90192-X"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.8.2934.420k07_2934_2939"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69049.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365519709057816"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.1052"},{"issue":"5","key":"e_1_2_8_20_2","first-page":"660","article-title":"Effects of subcutaneous recombinant erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron\u2010deficient erythropoiesis","volume":"123","author":"Brugnara C","year":"1994","journal-title":"J Lab Clin Med."},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.323"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00627.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.7.1416"},{"issue":"1","key":"e_1_2_8_24_2","first-page":"42","article-title":"Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients","volume":"53","author":"Canavese C","year":"2000","journal-title":"Clin Nephrol."},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027317"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2554-7_14"},{"key":"e_1_2_8_27_2","first-page":"4879","article-title":"Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokine and iron","volume":"90","author":"Tran TN","year":"1997","journal-title":"Blood."},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.43"},{"issue":"191","key":"e_1_2_8_29_2","first-page":"369","article-title":"Iron metabolism in haemodialysis patients: a study of the management of iron therapy and overload","volume":"48","author":"Gokal R","year":"1979","journal-title":"Q J Med."},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69119.x"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0030"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69125.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2001.06894.x"},{"issue":"1","key":"e_1_2_8_34_2","first-page":"19","article-title":"The role of iron in cancer","volume":"5","author":"Weinberg ED","year":"1996","journal-title":"Eur J Cancer Prev."},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/5.7.504"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.161.6.1593"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0018"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00370.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.15.8.1172"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.9.1222"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00976.x"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36334"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36853"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1492-7535.2003.00040.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1492-7535.2003.00040.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1492-7535.2003.00040.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:38:25Z","timestamp":1697215105000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1492-7535.2003.00040.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1046\/j.1492-7535.2003.00040.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1492-7535.2003.00040.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}